I saw the graph to load fibroscan values. And I do not understand why he told me f3 / f4.
For 6 months, or when I'm done with therapy, I'll do again FibroScan, and we'll see if something changes.
That the last fibroskan only result that I have (along with biopsy from a year ago, which has resulted in F1, and blood analyzes, which show slight discrepancies in AST under 50, and ALT under 70, AST always smaller than the ALT ...), it would probably chose 12 weeks of therapy.
I'm worried about previous fibroskan of 16.3 kPa. What I was made a month ago, while I had a mild form of flu - a runny nose and hoarseness ...
Enkel, thanks for quotes. I'm watching the trial, and study times and I conclude that we should go to 12 weeks ...
However, given that I bought therapy for 24 weeks, I'm ready to extend. The question is whether that can do damage to me?
If I do not succeed with the first treatment, whether its length affects the likelihood of success following treatment?
I'd like to hear more advice. The doctor who follows me, (which we clearly said that there is no experience with these drugs), recommended me to go to 24 weeks.
G1 F1 or F4 (I am not sure) 6. jan. 2014. -> Biopsy -> F1
24. dec. 2015 -> Fibroscan 16.3 kPa -> indicate chirosis
15. Jan. 2016 -> Fibroscan 10.2 kPa -> F3/F4
VL 30.000.000 - may 2015
VL 3.300.000 - dec 2015
Started TWINVIR treatment naive on January 13, 2016.
VL after 21 day UNDETECTED